DR HOENLE AG(FRA:HNL) stock Fundamental Analysis

Fundamental Rating

Overall HNL gets a fundamental rating of 3 out of 10. We evaluated HNL against 53 industry peers in the Electrical Equipment industry. HNL may be in some trouble as it scores bad on both profitability and health. HNL has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

HNL had negative earnings in the past year.

In the past year HNL had a positive cash flow from operations.

HNL had negative earnings in 4 of the past 5 years.

HNL had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -8.45%, HNL is not doing good in the industry: 69.81% of the companies in the same industry are doing better.

HNL's Return On Equity of -16.43% is on the low side compared to the rest of the industry. HNL is outperformed by 64.15% of its industry peers.

		Industry Rank	Sector Rank
ROA	-8.45%
ROE	-16.43%
ROIC	N/A

ROA(3y)-7.21%

ROA(5y)-4.22%

ROE(3y)-13.57%

ROE(5y)-8.04%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 59.82%, HNL belongs to the best of the industry, outperforming 83.02% of the companies in the same industry.

HNL's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for HNL so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	59.82%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.43%

GM growth 5Y-2.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HNL does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for HNL remains at a similar level compared to 1 year ago.

Compared to 5 years ago, HNL has more shares outstanding

The debt/assets ratio for HNL is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.39, we must say that HNL is in the distress zone and has some risk of bankruptcy.

HNL's Altman-Z score of 1.39 is in line compared to the rest of the industry. HNL outperforms 50.94% of its industry peers.

HNL has a debt to FCF ratio of 38.25. This is a negative value and a sign of low solvency as HNL would need 38.25 years to pay back of all of its debts.

Looking at the Debt to FCF ratio, with a value of 38.25, HNL is in line with its industry, outperforming 49.06% of the companies in the same industry.

HNL has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.48, HNL is in line with its industry, outperforming 49.06% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.48
Debt/FCF	38.25
Altman-Z	1.39

ROIC/WACCN/A

WACC6.25%

2.3 Liquidity

HNL has a Current Ratio of 1.89. This is a normal value and indicates that HNL is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.89, HNL is in line with its industry, outperforming 58.49% of the companies in the same industry.

HNL has a Quick Ratio of 1.89. This is a bad value and indicates that HNL is not financially healthy enough and could expect problems in meeting its short term obligations.

HNL has a Quick ratio (0.86) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.89
Quick Ratio	0.86

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HNL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.33%.

HNL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.96%.

HNL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.73% yearly.

EPS 1Y (TTM)-8.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%34.91%

Revenue 1Y (TTM)-25.96%

Revenue growth 3Y-5%

Revenue growth 5Y-1.73%

Sales Q2Q%-9.99%

3.2 Future

The Earnings Per Share is expected to grow by 36.78% on average over the next years. This is a very strong growth

Based on estimates for the next years, HNL will show a small growth in Revenue. The Revenue will grow by 6.84% on average per year.

EPS Next Y105.88%

EPS Next 2Y55.11%

EPS Next 3Y36.78%

EPS Next 5YN/A

Revenue Next Year4.63%

Revenue Next 2Y7.31%

Revenue Next 3Y8.69%

Revenue Next 5Y6.84%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HNL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

HNL is valuated correctly with a Price/Forward Earnings ratio of 14.35.

Compared to the rest of the industry, the Price/Forward Earnings ratio of HNL indicates a somewhat cheap valuation: HNL is cheaper than 73.58% of the companies listed in the same industry.

HNL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.44.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	14.35

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HNL.

The rest of the industry has a similar Price/Free Cash Flow ratio as HNL.

		Industry Rank	Sector Rank
P/FCF	42.74
EV/EBITDA	30.32

4.3 Compensation for Growth

HNL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as HNL's earnings are expected to grow with 36.78% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y55.11%

EPS Next 3Y36.78%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HNL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DR HOENLE AG

FRA:HNL (5/9/2025, 7:00:00 PM)

+0.32 (+3.31%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)02-25 2025-02-25

Earnings (Next)05-08 2025-05-08

Inst Owners21.44%

Inst Owner ChangeN/A

Ins Owners5.99%

Ins Owner ChangeN/A

Market Cap60.60M

Analysts83.33

Price Target19.89 (98.9%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.02

Dividend Growth(5Y)-49.2%

DP-0.95%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)11.11%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)1.23%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	14.35
P/S	0.63
P/FCF	42.74
P/OCF	16.87
P/B	0.77
P/tB	0.91
EV/EBITDA	30.32

EPS(TTM)-2.14

EYN/A

EPS(NY)0.7

Fwd EY6.97%

FCF(TTM)0.23

FCFY2.34%

OCF(TTM)0.59

OCFY5.93%

SpS15.9

BVpS13.02

TBVpS10.94

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-8.45%
ROE	-16.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	59.82%
FCFM	1.47%

ROA(3y)-7.21%

ROA(5y)-4.22%

ROE(3y)-13.57%

ROE(5y)-8.04%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.43%

GM growth 5Y-2.54%

F-Score4

Asset Turnover0.63

Health

		Industry Rank	Sector Rank
Debt/Equity	0.48
Debt/FCF	38.25
Debt/EBITDA	10.94
Cap/Depr	16.44%
Cap/Sales	2.26%
Interest Coverage	N/A
Cash Conversion	103.31%
Profit Quality	N/A
Current Ratio	1.89
Quick Ratio	0.86
Altman-Z	1.39

F-Score4

WACC6.25%

ROIC/WACCN/A

Cap/Depr(3y)25.04%

Cap/Depr(5y)131.73%

Cap/Sales(3y)2.86%

Cap/Sales(5y)11.12%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-8.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%34.91%

EPS Next Y105.88%

EPS Next 2Y55.11%

EPS Next 3Y36.78%

EPS Next 5YN/A

Revenue 1Y (TTM)-25.96%

Revenue growth 3Y-5%

Revenue growth 5Y-1.73%

Sales Q2Q%-9.99%

Revenue Next Year4.63%

Revenue Next 2Y7.31%

Revenue Next 3Y8.69%

Revenue Next 5Y6.84%

EBIT growth 1Y3.33%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year182.59%

EBIT Next 3Y51.43%

EBIT Next 5YN/A

FCF growth 1Y157.32%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y98.23%

OCF growth 3Y69.79%

OCF growth 5Y-20.04%

DR HOENLE AG (HNL.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens